Market Research Logo

US Market Overview for Vascular Access Devices and Accessories 2016 - MedView

The U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound machines, tip guidance devices, catheter securement devices, syringes and needles.


EXECUTIVE SUMMARY
1.1 U.S. VASCULAR ACCESS DEVICES AND ACCESSORIES MARKET OVERVIEW
1.2 COMPETITIVE LANDSCAPE
1.3 MARKET TRENDS
1.4 KEY MARKET DEVELOPMENTS
1.5 MARKETS INCLUDED
1.6 PROCEDURES INCLUDED
1.7 PROCEDURE CODES INVESTIGATED
1.8 KEY REPORT UPDATES
1.9 VERSION HISTORY
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
3.1 BASIC ANATOMY
3.1.1 Human Vascular System
3.2 VASCULAR PATHOLOGY AND DISORDERS
3.2.1 Cancer
3.2.2 End-Stage Renal Disease
3.2.3 Diabetes
3.3 PATIENT DEMOGRAPHICS
3.3.1 Cancer
3.3.1.1 Digestive Cancer
3.3.1.2 Genital Cancer
3.3.1.3 Breast Cancer
3.3.1.4 Respiratory Cancer
3.3.1.5 Urinary Cancer
3.3.1.6 Skin Cancer
3.3.1.7 Lymphoma
3.3.1.8 Endocrine System Cancer
3.3.1.9 Leukemia
3.3.1.10 Oral Cavity/Larynx
3.3.1.11 Myeloma
3.3.1.12 Brain/Other Nervous System
3.3.1.13 Soft Tissue (including heart)
3.3.1.14 Bones and Joints
3.3.1.15 Eye and Orbit
3.3.2 End-Stage Renal Disease
3.3.2.1 End-Stage Renal Disease Incidence
3.3.2.1.1 End-Stage Renal Disease Incident Cases by Modality
3.3.2.1.2 End-Stage Renal Disease Incident Cases by Age Group
3.3.2.1.3 End-Stage Renal Disease Incident Cases Using Home Dialysis by Therapy
3.3.2.2 Vascular Access Use at Hemodialysis Initiation
3.3.2.2.1 Vascular Access Use During First Year of Hemodialysis
3.3.2.2.1.1 Vascular Access Use During First Year of Hemodialysis by Age Group End
3.3.2.3 Stage Renal Disease Prevalence
3.3.2.3.1 End-Stage Renal Disease Prevalent Cases by Modality
3.3.2.3.1.1 Prevalent Hemodialysis Patients by Vascular Access Type
3.3.2.3.2 End-Stage Renal Disease Prevalent Cases by Age Group
3.3.2.3.3 End-Stage Renal Disease Prevalent Cases Using Home Dialysis by Therapy
3.3.3 Diabetes
3.3.3.1 Diagnosed Diabetes Incidence Amongst Adults
3.3.3.1.1 Diagnosed Diabetes Incidence Amongst Adults by State
3.3.3.2 Diagnosed Diabetes Prevalence Amongst Adults
3.3.3.2.1 Diagnosed Diabetes Prevalence Amongst Adults by Medication Status
3.3.3.2.2 Diagnosed Diabetes Prevalence Amongst Adults by State and Age Group
3.3.3.2.3 Diagnosed Diabetes Prevalence Amongst Adults by State and Gender
PRODUCT ASSESSMENT
4.1 PRODUCT PORTFOLIOS
4.1.1 Implantable Port Devices
4.1.1.1 Introduction
4.1.1.1.1 Implantable Port Patients
4.1.1.1.2 Port Implantation Procedures
4.1.1.1.3 Port Infusion
4.1.1.1.4 Port Maintenance
4.1.2 Port Needles
4.1.2.1 Introduction
4.1.3 Central Venous Catheters
4.1.3.1 Introduction
4.1.3.1.1 CVC Procedures
4.1.3.1.2 CVC Kits
4.1.3.1.3 CVC Market Segments
4.1.4 Peripherally Inserted Central Catheters
4.1.4.1 Introduction
4.1.4.1.1 PICC Placement
4.1.5 Peripheral Intravenous Catheters
4.1.6 Dialysis Catheters
4.1.6.1 Introduction
4.1.6.1.1 AV Fistulae
4.1.6.1.2 AV Grafts
4.1.6.1.3 Dialysis Catheters
4.1.7 Ultrasound Vascular Access Devices
4.1.7.1 Introduction
4.1.7.1.1 Alternates to Ultrasound Guidance
4.1.7.1.2 Ultrasound Guidance
4.1.7.1.3 Ultrasound Vessel Mapping
4.1.7.1.4 Tip Location
4.1.7.1.5 General Ultrasound Imaging Systems with Vascular Access Guidance Capabilities Market
4.1.8 Catheter Securement Devices
4.1.8.1 Introduction
4.1.8.1.1 Catheter Stabilization Methods
4.1.9 Syringe and Needles
4.1.9.1 Introduction
U.S. VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW
5.1 MARKET OVERVIEW
5.2 TREND ANALYSIS
5.3 DRIVERS AND LIMITERS
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 COMPETITIVE MARKET SHARE ANALYSIS
5.5 COMPANY PROFILES
5.5.1 3 M
5.5.2 AngioDynamics
5.5.3 Becton Dickinson
5.5.4 C.R. Bard
5.5.5 FUJIFILM SonoSite, Inc.
5.5.7 Johnson & Johnson
5.5.8 Medcomp
5.5.9 Medtronic
5.5.10 Smith & Nephew
5.5.11 Smiths Medical
5.5.12 Teleflex Medical
5.6 SWOT ANALYSIS
5.6.1 Becton Dickinson
5.6.2 C.R. Bard
5.6.3 FUJIFILM SonoSite, Inc.
5.6.4 GE Healthcare
5.6.5 Medtronic
5.6.6 Smiths Medical
5.6.7 Teleflex Medical
5.7 MERGERS AND ACQUISITIONS
5.7.1 Teleflex Acquires Nostix, LLC
5.7.2 The Vygon Group Acquires Perouse Medical
5.7.3 Roundtable Healthcare Partners Acquires TIDI Products
5.7.4 C.R. Bard Acquires Vascular Pathways, Inc.
5.7.5 3 M Acquires Ivera Medical Corporation
5.7.6 Medtronic Acquires Covidien
5.7.7 TIDI Products Acquires Catheter Securement Business from Zefon International
5.7.8 AngioDynamics Acquires Rights to Celerity™ System from Medcomp
5.7.9 C.R. Bard Acquires PICC Technology from 3 DT Holdings LLC
5.7.10 Becton Dickinson Acquires Safety Syringes Inc.
5.7.11 Endeavor Capital Acquires Access Scientific, Inc.
5.7.12 Teleflex Medical Acquires Semprus BioSciences
5.7.13 AngioDynamics Acquires Navilyst Medical
5.7.14 Vygon Signs Distribution Agreement with Ambu Inc.
5.7.15 Fujifilm Holdings Corporation Acquires SonoSite, Inc.
List of Chart
Chart 0-1: Vascular Access Device Market by Segment, U.S., 2012 – 2022
Chart 0-2: Vascular Access Device Market Overview, U.S., 2015 and 2022
Chart 3-1: Male Incidence, Digestive Cancer, U.S., 2016
Chart 3-2: Male Deaths, Digestive Cancer, U.S., 2016
Chart 3-3: Female Incidence, Digestive Cancer, U.S., 2016
Chart 3-4: Female Deaths, Digestive Cancer, U.S., 2016
Chart 3-5: Male Incidence, Genital Cancer, U.S., 2016
Chart 3-6: Male Deaths, Genital Cancer, U.S., 2016
Chart 3-7: Female Incidence, Genital Cancer, U.S., 2016
Chart 3-8: Female Deaths, Genital Cancer, U.S., 2016
Chart 3-9: Incidence by Gender, Breast Cancer, U.S., 2016
Chart 3-10: Deaths by Gender, Breast Cancer, U.S., 2016
Chart 3-11: Male Incidence, Respiratory Cancer, U.S., 2016
Chart 3-12: Male Deaths, Respiratory Cancer, U.S., 2016
Chart 3-13: Female Incidence, Respiratory Cancer, U.S., 2016
Chart 3-14: Female Deaths, Respiratory Cancer, U.S., 2016
Chart 3-15: Male Incidence, Urinary Cancer, U.S., 2016
Chart 3-16: Male Deaths, Urinary Cancer, U.S., 2016
Chart 3-17: Female Incidence, Urinary Cancer, U.S., 2016
Chart 3-18: Female Deaths, Urinary Cancer, U.S., 2016
Chart 3-19: Male Incidence, Skin Cancer, U.S., 2016
Chart 3-20: Male Deaths, Skin Cancer, U.S., 2016
Chart 3-21: Female Incidence, Skin Cancer, U.S., 2016
Chart 3-22: Female Deaths, Skin Cancer, U.S., 2016
Chart 3-23: Male Incidence, Lymphoma Cancer, U.S., 2016
Chart 3-24: Male Deaths, Lymphoma Cancer, U.S., 2016
Chart 3-25: Female Incidence, Lymphoma Cancer, U.S., 2016
Chart 3-26: Female Deaths, Lymphoma Cancer, U.S., 2016
Chart 3-27: Male Incidence, Endocrine Cancer, U.S., 2016
Chart 3-29: Female Incidence, Endocrine Cancer, U.S., 2016
Chart 3-30: Female Deaths, Endocrine Cancer, U.S., 2016
Chart 3-31: Male Incidence, Leukemia Cancer, U.S., 2016
Chart 3-32: Male Deaths, Leukemia Cancer, U.S., 2016
Chart 3-33: Female Incidence, Leukemia Cancer, U.S., 2016
Chart 3-34: Female Deaths, Leukemia Cancer, U.S., 2016
Chart 3-35: Male Incidence, Oral Cavity/Larynx Cancer, U.S., 2016
Chart 3-36: Male Deaths, Oral Cavity/Larynx Cancer, U.S., 2016
Chart 3-37: Female Incidence, Oral Cavity/Larynx Cancer, U.S., 2016
Chart 3-38: Female Deaths, Oral Cavity/Larynx Cancer, U.S., 2016
Chart 3-39: Incidence by Gender, Myeloma Cancer, U.S., 2016
Chart 3-40: Deaths by Gender, Myeloma Cancer, U.S., 2016
Chart 3-41: Incidence by Gender, Brain/Other Nervous System Cancer, U.S., 2016
Chart 3-42: Deaths by Gender, Brain/Other Nervous System Cancer, U.S., 2016
Chart 3-43: Incidence by Gender, Soft Tissue Cancer, U.S., 2016
Chart 3-44: Deaths by Gender, Soft Tissue Cancer, U.S., 2016
Chart 3-45: Incidence by Gender, Bone and Joint Cancers, U.S., 2016
Chart 3-46: Deaths by Gender, Bone and Joint Cancers, U.S., 2016
Chart 3-47: Incidence by Gender, Eye and Orbit Cancers, U.S., 2016
Chart 3-48: Deaths by Gender, Eye and Orbit Cancers, U.S., 2016
Chart 3-49: End-Stage Renal Disease Incident Cases, U.S., 1996 – 2015
Chart 3-50: End-Stage Renal Disease Incident Cases by Modality, U.S., 1996 – 2015
Chart 3-51: End-Stage Renal Disease Incident Cases by Age Group, U.S., 1996 – 2015
Chart 3-52: End-Stage Renal Disease Incident Cases Using Home Dialysis by Therapy, U.S., 1996 – 2015 83
Chart 3-53: Vascular Access Use at Hemodialysis Initiation, U.S., 2005 – 2015
Chart 3-54: Vascular Access Use During First Year of Hemodialysis, U.S., 2013 – 2014
Chart 3-55: End-Stage Renal Disease Prevalent Case Count, U.S., 1996 – 2015
Chart 3-56: End-Stage Renal Disease Prevalent Cases by Modality, U.S., 1996 – 2015
Chart 3-57: Prevalent Hemodialysis Patients by Vascular Access Type, U.S., 2003 – 2015
Chart 3-58: End-Stage Renal Disease Prevalent Cases by Age Group, U.S., 1996 – 2015
Chart 3-59: End-Stage Renal Disease Prevalent Cases Using Home Dialysis by Therapy, U.S., 1996 – 2015
Chart 3-60: Diagnosed Diabetes Incidence Count Adults, U.S., 1997 – 2015
Chart 4-1: Central Venous Catheter Market Segments, U.S., 2015
Chart 5-1: Total Vascular Access Device Market, U.S., 2012 – 2022
Chart 5-2: Vascular Access Devices and Accessories Market by Segment, U.S., 2012 – 2022
Chart 5-3: Vascular Access Devices and Accessories Market Breakdown, U.S., 2015
Chart 5-4: Vascular Access Devices and Accessories Market Breakdown, U.S., 2022
Chart 5-5: Growth Rates by Segment, Vascular Access Devices and Accessories Market, U.S., 2012 – 2022
Chart 5-6: Leading Competitors, Vascular Access Device Market, U.S., 2015
List of Figures
Figure 0-1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, U.S., 2015 (1 of 2)
Figure 0-2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, U.S., 2015 (2 of 2)
Figure 0-3: Companies Researched in Report, U.S., 2015
Figure 0-4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, U.S.
Figure 0-5: Recent Events in the Vascular Access Device and Accessories Market, U.S., 2012 – 2015
Figure 0-6: Vascular Access Devices & Accessories Markets Covered, U.S., 2015 (1 of 3)
Figure 0-7: Vascular Access Devices & Accessories Markets Covered, U.S., 2015 (2 of 3)
Figure 0-8: Vascular Access Devices & Accessories Markets Covered, U.S., 2015 (3 of 3)
Figure 0-9: Vascular Access Devices & Accessories Procedures Covered, U.S., 2015
Figure 0-10: Procedural Codes, U.S., 2015
Figure 0-11: Key Report Updates, U.S., 2014 and 2016 (1 of 2)
Figure 0-12: Key Report Updates, U.S., 2014 and 2016 (2 of 2)
Figure 0-13: Version History
Figure 3-1: Digestive Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-2: Genital Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-3: Breast Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-4: Respiratory Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-5: Urinary Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-6: Skin Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-7: Lymphoma Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-8: Endocrine Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-9: Leukemia Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-10: Oral Cavity/Larynx Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-11: Myeloma Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-12: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-13: Soft Tissue (Including Heart) Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-14: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2016
Figure 3-15: Eye and Orbit Statistics by Type and Gender, U.S., 2016
Figure 3-16: End-Stage Renal Disease Incident Cases, U.S., 1996 – 2015
Figure 3-17: End-Stage Renal Disease Incident Cases by Modality, U.S., 1996 – 2015
Figure 3-18: End-Stage Renal Disease Incident Cases by Age Group, U.S., 1996 – 2015
Figure 3-19: End-Stage Renal Disease Incident Cases Using Home Dialysis by Therapy, U.S., 1996 – 2015
Figure 3-20: Vascular Access Use at Hemodialysis Initiation, U.S., 2005 – 2015
Figure 3-21: Vascular Access Use During First Year of Hemodialysis, U.S., 2013 – 2014
Figure 3-22: Vascular Access Use During First Year of Hemodialysis by Age Group, U.S., 2013 – 2014
Figure 3-23: Vascular Access Use During First Year of Hemodialysis by Sex, U.S., 2013 – 2014
Figure 3-24: End-Stage Renal Disease Prevalent Case Count, U.S., 1996 – 2015
Figure 3-25: End-Stage Renal Disease Prevalent Cases by Modality, U.S., 1996 – 2015
Figure 3-26: Prevalent Hemodialysis Patients by Vascular Access Type, U.S., 2003 – 2015
Figure 3-27: End-Stage Renal Disease Prevalent Cases by Age Group, U.S., 1996 – 2015
Figure 3-28: End-Stage Renal Disease Prevalent Cases Using Home Dialysis by Therapy, U.S., 1996 – 2015
Figure 3-29: Diagnosed Diabetes Incidence Count Adults, U.S., 1997 – 2015
Figure 3-30: Diagnosed Diabetes Incidence Age-Adjusted Rate per 1000 Adults by State, U.S., 2014 (1 of 2)
Figure 3-31: Diagnosed Diabetes Incidence Age-Adjusted Rate per 1000 Adults by State, U.S., 2014 (2 of 2)
Figure 3-32: Diagnosed Diabetes Prevalence Count Adults, U.S., 1997 – 2015
Figure 3-33: Diagnosed Diabetes Prevalence Count Adults by Medication Status, U.S., 1997 – 2015
Figure 3-34: Diagnosed Diabetes Prevalence Age-Adjusted Rate per 100 Adults by State and Age Group, U.S., 2014 (1 of 2)
Figure 3-35: Diagnosed Diabetes Prevalence Age-Adjusted Rate per 100 Adults by State and Age Group, U.S., 2014 (2 of 2)
Figure 3-36: Diagnosed Diabetes Prevalence Age-Adjusted Rate per 100 Adults by State and Gender, U.S., 2014 (1 of 2)
Figure 3-37: Diagnosed Diabetes Prevalence Age-Adjusted Rate per 100 Adults by State and Gender, U.S., 2014 (2 of 2)
Figure 5-1: Total Vascular Access Device Market, U.S., 2012 – 2022 (US$M)
Figure 5-2: Vascular Access Devices and Accessories Market by Segment, U.S., 2012 – 2022 (US$M) (1 of 2)
Figure 5-3: Vascular Access Devices and Accessories Market by Segment, U.S., 2012 – 2022 (US$M) (2 of 2)
Figure 5-4: Growth Rates by Segment, Vascular Access Devices and Accessories Market, U.S., 2012 – 2022 (1 of 2)
Figure 5-5: Growth Rates by Segment, Vascular Access Devices and Accessories Market, U.S., 2012 – 2022 (2 of 2)
Figure 5-6: Drivers and Limiters, Vascular Access Devices and Accessories Market, U.S., 2015
Figure 5-7: Leading Competitors, Vascular Access Device Market, U.S., 2015 (1 of 2)
Figure 5-8: Leading Competitors, Vascular Access Device Market, U.S., 2015 (2 of 2)
Figure 5-9: SWOT Analysis, Becton Dickinson, 2015
Figure 5-10: SWOT Analysis, C.R. Bard, 2015
Figure 5-11: SWOT Analysis, FUJIFILM SonoSite, Inc., 2015
Figure 5-12: SWOT Analysis, GE Healthcare, 2015
Figure 5-13: SWOT Analysis, Medtronic, 2015
Figure 5-14: SWOT Analysis, Smiths Medical, 2015
Figure 5-15: SWOT Analysis, Teleflex Medical, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report